(+)-4-Propyl-9-hydroxynaphthoxazine (PHNO), a new dopaminomimetic, in treatment of parkinsonism.

Stoessl, A J

(+)-4-Propyl-9-hydroxynaphthoxazine (PHNO), a new dopaminomimetic, in treatment of parkinsonism. [electronic resource] - Lancet (London, England) Dec 1985 - 1330-1 p. digital

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0140-6736

10.1016/s0140-6736(85)92627-3 doi


Adult
Aged
Clinical Trials as Topic
Dopamine--physiology
Double-Blind Method
Female
Humans
Male
Middle Aged
Oxazines--adverse effects
Parkinson Disease--drug therapy
Time Factors